Cellebrite DI Ltd.
CLBT
$17.09
$0.482.89%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 18.35% | 17.24% | 24.82% | 25.76% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 18.35% | 17.24% | 24.82% | 25.76% | |
| Cost of Revenue | 8.71% | 18.16% | 24.79% | 6.92% | |
| Gross Profit | 20.32% | 17.07% | 24.82% | 29.73% | |
| SG&A Expenses | 16.63% | 21.17% | 13.95% | 16.81% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 16.26% | 19.62% | 15.50% | 12.99% | |
| Operating Income | 32.27% | 4.85% | 170.11% | 6,699.26% | |
| Income Before Tax | 194.44% | 261.17% | 29.95% | -79.43% | |
| Income Tax Expenses | -26.78% | -72.72% | 95.22% | 3.92% | |
| Earnings from Continuing Operations | 181.79% | 231.56% | 26.39% | -75.77% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 181.79% | 231.56% | 26.39% | -75.77% | |
| EBIT | 32.27% | 4.85% | 170.11% | 6,699.26% | |
| EBITDA | 26.86% | 4.78% | 109.44% | 361.75% | |
| EPS Basic | 167.67% | 209.69% | 30.37% | -66.41% | |
| Normalized Basic EPS | 185.98% | 234.26% | 33.72% | -- | |
| EPS Diluted | 166.17% | 197.16% | 32.59% | -66.41% | |
| Normalized Diluted EPS | 183.09% | 226.70% | 33.72% | -- | |
| Average Basic Shares Outstanding | 20.81% | 19.96% | 5.75% | 5.63% | |
| Average Diluted Shares Outstanding | 25.15% | 27.21% | 5.75% | 5.63% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |